U.S. Probes Drug Supply Chain Risks to Boost Domestic Output
WASHINGTON, D.C. — The federal government is examining U.S. production capacity and foreign sourcing dependencies for chemicals used to manufacture medicines, an assessment intended to identify supply chain vulnerabilities and …
U.S. Probes Drug Supply Chain Risks to Boost Domestic Output Read More